Results below are sorted by descending Start and End Dates and ascending Title.
| Type | Start Date | End Date | Awardee(s) | Title |
|---|---|---|---|---|
| Adult Children Study Project | July 1, 2021 | April 30, 2026 | Denise P. Head | Project 4 Mechanisms and Moderators of the Effects of Physical Activity in Preclinical Alzheimer Disease |
| Knight ADRC Project | May 1, 2020 | April 30, 2022 | Nicolas Regis Barthelemy | Project 1.1 CSF tau phosphorylation changes over the course of late onset Alzheimer Disease |
| Knight ADRC Project | May 1, 2020 | April 30, 2022 | Mark S. Sands | Project 1.2 Haploinsufficiency of Lysosomal Enzymes and Alzheimer Disease |
| HASD Project | May 1, 2019 | April 30, 2024 | John C. Morris | Project 1 Characterization of molecular biomarker profiles of AD throughout its pathobiolgical continuum |
| HASD Project | May 1, 2019 | April 30, 2024 | Brendan Patrick Lucey | Project 2 Sleep and Orexin: Potential Markers of Progression from Preclinical to Mildly Symptomatic Alzheimer’s Disease |
| HASD Project | May 1, 2019 | April 30, 2024 | Carlos Cruchaga | Project 3 Dissecting the Genetic Architecture of Cognitive Reserve and Resilience |
| HASD Project | May 1, 2019 | April 30, 2024 | Jason J. Hassenstab | Project 4 Smartphone-Based “Burst” Cognitive Assessments |
| Adult Children Study Project | September 30, 2016 | May 31, 2021 | John C. Morris | Project 1 Preclinical Predictors of Progression from Cognitive Normality to Impairment |
| Adult Children Study Project | September 30, 2016 | May 31, 2021 | Anne Fagan | Project 2 CSF biomarkers of AD progression |
| Adult Children Study Project | September 30, 2016 | May 31, 2021 | David A. Balota | Project 3 Attentional Control, Sleep and Memory Consolidation: The role of AD biomarkers |
Close this window/tab to return to the Developmental Projects page.